We are building a world-class biopharmaceutical company with a dedicated team of management and advisors with therapeutic area expertise in severe pulmonary diseases and respiratory drug development. 

  • John Taylor - President & CEO
  • Alistair Wheeler, MD MFPM - Chief Medical Officer
  • Timm Crowder, PhD - SVP, Technical Operations
  • Rob Tarran, PhD - Scientific Founder & Chair, SAB